Oaktree Acquisition Corp. III Life Sciences (OACCU) Change in Accured Expenses (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences' (OACCU) quarterly Change in Accured Expenses came in at $249496.0 in Q1 2026, up 278.43% YoY from $65929.3 in Q1 2025, and up 183.96% on a QoQ basis from $87863.0 in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACCU) Change in Accured Expenses (2025 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences (OACCU) has 2 years of Change in Accured Expenses data on file, last reported at $249496.0 in Q1 2026.
- Quarterly Change in Accured Expenses rose 278.43% year-over-year to $249496.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $355780.0 (changed N/A YoY) and the FY2025 annual result came in at -$33545.0, down 106.26% from the prior year.
- Change in Accured Expenses rose to $249496.0 in Q1 2026, from $87863.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $249496.0 in Q1 2026 to a low of -$139829.0 in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30,688.00 |
| Jun 30, 2026 | 30,688.00 |
| Mar 31, 2026 | 249,496.00 |
| Mar 31, 2026 | 249,496.00 |
| Dec 31, 2025 | 87,863.00 |
| Dec 31, 2025 | 87,863.00 |
| Sep 30, 2025 | -31,424.00 |
| Sep 30, 2025 | -31,424.00 |
| Jun 30, 2025 | 49,845.00 |
| Jun 30, 2025 | 49,845.00 |
| Mar 31, 2025 | -139,829.00 |
| Mar 31, 2025 | -139,829.00 |